BIFIDO Co., Ltd. (238200.KQ)

5,010.00 -50.00 (-0.99%) At close: 03:02PM KST

BIFIDO Co., Ltd.

23-16 Nonggongdanji-gil
Hongcheon-eup
Hongcheon
South Korea
82 3 3435 4962
https://www.bifido.com

Sector(s): 
Industry: 
Full-time employees: 

Description

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.

Corporate governance

BIFIDO Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.